CompletedNot Applicable

Effects of Glutamine on GLP-1 and Insulin Secretion in Man

Australia22 participantsStarted 2008-04

Plain-language summary

This study investigated the effect of glutamine, an amino acid, glycemia, glucagon-like peptide-1 (GLP-1) and insulin in participants with type 2 diabetes.

Who can participate

Age range40 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Type 2 diabetes, on metformin or diet alone (not sulphonylureas or insulin) Exclusion Criteria: * Malabsorption, renal or liver disease, treatment with steroids

What they're measuring

Postprandial Glucose Area Under the Curve (AUC)

Timeframe: 0 to 180 minutes

Trial details

NCT IDNCT00673894

SponsorGarvan Institute of Medical Research

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2011-12

Results submitted2017-09-21

View on ClinicalTrials.gov More Type 2 Diabetes trials